Literature DB >> 7317342

An investigation of the effects of intravenous administration of thiomolybdate on copper metabolism in chronic Cu-poisoned sheep.

S R Gooneratne, J M Howell, J M Gawthorne.   

Abstract

1. Fourteen sheep were dosed repeatedly with a solution of copper sulphate (2 g/l) in order to induce chronic copper poisoning and four similar undosed animals acted as controls 2. Thiomolybdate (TM) was intravenously administered to all control sheep and to all except two of the test sheep. A variety of biochemical factors were studied before and after injections of TM. 3. The direct-reacting Cu, whole-blood Cu and plasma Cu concentrations were elevated in animals given TM injections and at the "haemolytic crisis" of untreated chronic Cu-poisoned animals. But most of the increased Cu observed on injecting TM was insoluble in trichloroacetic acid (TCA) and did not enter erythrocytes. The results indicate that uptake of Cu by erythrocytes is essential for haemolysis to occur and that for this to happen the Cu must be in a direct reacting, TCA-soluble form. 4. Increased amounts of Cu were excreted in the urine at haemolysis and at commencement of TM injections. High levels of direct-reacting Cu were found in plasma at these times. 5. Marked changes were not found in caeruloplasmin activity, packed cell volume or the osmotic fragility of erythrocytes except at haemolysis. TM injection s did no alter these factors in any of the sheep studied.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7317342     DOI: 10.1079/bjn19810055

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  6 in total

1.  Copper chelation by tetrathiomolybdate inhibits lipopolysaccharide-induced inflammatory responses in vivo.

Authors:  Hao Wei; Balz Frei; Joseph S Beckman; Wei-Jian Zhang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-07-01       Impact factor: 4.733

2.  Clinical trials of penicillamine in Indian childhood cirrhosis.

Authors:  M S Tanner; S A Bhave; A M Pradhan; A N Pandit
Journal:  Arch Dis Child       Date:  1987-11       Impact factor: 3.791

Review 3.  Mapping brain metals to evaluate therapies for neurodegenerative disease.

Authors:  Bogdan Florin Gh Popescu; Helen Nichol
Journal:  CNS Neurosci Ther       Date:  2010-06-14       Impact factor: 5.243

Review 4.  Practical recommendations and new therapies for Wilson's disease.

Authors:  G J Brewer
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

5.  Copper Chelation as Targeted Therapy in a Mouse Model of Oncogenic BRAF-Driven Papillary Thyroid Cancer.

Authors:  MengMeng Xu; Michael Casio; Danielle E Range; Julie A Sosa; Christopher M Counter
Journal:  Clin Cancer Res       Date:  2018-07-31       Impact factor: 13.801

6.  Bis-choline tetrathiomolybdate prevents copper-induced blood-brain barrier damage.

Authors:  Sabine Borchard; Stefanie Raschke; Krzysztof M Zak; Carola Eberhagen; Claudia Einer; Elisabeth Weber; Sandra M Müller; Bernhard Michalke; Josef Lichtmannegger; Albrecht Wieser; Tamara Rieder; Grzegorz M Popowicz; Jerzy Adamski; Martin Klingenspor; Andrew H Coles; Ruth Viana; Mikkel H Vendelbo; Thomas D Sandahl; Tanja Schwerdtle; Thomas Plitz; Hans Zischka
Journal:  Life Sci Alliance       Date:  2021-12-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.